Potassium trifluoro(1-methyl-1H-pyrazol-5-yl)borate, 96.0%, 5g

1-METHYL-1H,2H,3H-PYRROLO[2,3-B]PYRIDIN-2-ONE, 95.0%, 500mg

6-Bromo-3-methoxy-2-nitrobenzoic acid, 95.0%, 5g

7-Chloro-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine, 97.0%, 1g

2-Chloro-6-fluoro-3-methoxybenzylamine, 1g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline, 95.0%, 1g

2-Phenoxypropanol>96.0%(GC)25g

5-Fluoronicotinaldehyde, 95.0%, 5g

(R)-2-Amino-3-(4-fluorophenyl)propanoic acid, 95.0%, 25g

2-Bromo-5-phenyl-1,3-oxazole, 95.0%, 5g

(3-4% Methylhydrosiloxane)-dimethylsiloxane co-polymer Trimethylsiloxane terminated, 25-25cSt, 100g

7-Methoxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one, 95%, 50mg

(2R,3R,4S,5R)-2-(2-Chloro-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 96.0%, 250mg